Empiai Pharmaceuticals Private Limited

Empiai Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1988PTC046461 Incorporated 09 March 1988 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Revenue · FY 2025
₹8.93 Cr
▲ 2% YoY
Net loss · FY 2025
₹94.63 Lakh
Net margin -10.6%
EBITDA · FY 2025
-₹90.87 Lakh
EBITDA margin -10.2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
38 yrs
Est. 1988
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Empiai Pharmaceuticals Private Limited

Data last updated:

Empiai Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 March 1988 and has been in existence for over 38 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1988PTC046461. Its GSTIN is 27AAACE1822H1Z0 (Maharashtra).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Ishan Kishore Adyanthaya and Rajesh Suvarna Sheena.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 102 Bhagat Singh Road Vile Parle (West), Mumbai, Maharashtra, India – 400056.

As per the financials filed for FY 2025, the company reported a revenue of ₹8.93 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net loss of ₹94.63 Lakh (net margin -10.6%) and EBITDA of -₹90.87 Lakh (EBITDA margin -10.2%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 3% over five years.

Court records list 2 cases involving the company, including 2 filed by the company.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24230MH1988PTC046461
Registration Number 046461
Incorporation Date 09 March 1988
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Empiai Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    102 Bhagat Singh Road Vile Parle (West), Mumbai, Maharashtra, India – 400056
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Empiai Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Empiai Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Empiai Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Empiai Pharmaceuticals Private Limited, buy the company report.

Financials of Empiai Pharmaceuticals Private Limited

FY 2025 filings available

Empiai Pharmaceuticals Private Limited reported revenue of ₹8.93 Cr (up 2% YoY) for FY 2025.

Revenue · FY 2025
₹8.93 Cr ▲ 2%
Net loss · FY 2025
₹94.63 Lakh margin -10.6%
EBITDA · FY 2025
-₹90.87 Lakh margin -10.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 3%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 33%
3 years · compounded
▼ 106%
5 years · compounded
▼ 32%

Revenue rose 2% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA fell 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹90.87 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹94.63 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-10.2%
Net Profit Margin-10.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Empiai Pharmaceuticals Private Limited, buy the company report.

Board of directors of Empiai Pharmaceuticals Private Limited

Empiai Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ishan Kishore AdyanthayaDirector07 Dec 20187 Years 11 MonthsCurrent
Rajesh Suvarna SheenaDirector01 Apr 200620 Years 7 MonthsCurrent

Auditor

Empiai Pharmaceuticals Private Limited is audited by MAJIBAIL & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
MAJIBAIL & COFY 2019105870W

Shareholding

The shareholding of Empiai Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Empiai Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Empiai Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Empiai Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACE1822H1Z0MaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Empiai Pharmaceuticals Private Limited, buy the company report.

Recent activity

Empiai Pharmaceuticals Private Limited has 4 board changes on record since 2006: 2 appointments and 2 cessations. The latest: Ishan Kishore Adyanthaya ceased to be Additional Director on 30 Sep 2019.

AGM
Empiai Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Empiai Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Ishan Kishore Adyanthaya ceased to be Additional Director.
Ceased
Pilar Padmanabha Bhat ceased to be Director.
Appointed
Ishan Kishore Adyanthaya was appointed as Director.
Appointed
Rajesh Suvarna Sheena was appointed as Director.
Incorporation
09 Mar 1988
Empiai Pharmaceuticals Private Limited was registered on 09 Mar 1988 with Roc Mumbai I & aged 38 years 8 months as per MCA records.

Frequently asked questions

Empiai Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 March 1988 (38+ years old) and is registered under CIN U24230MH1988PTC046461.

Empiai Pharmaceuticals has 2 current directors:

The latest financial statements of Empiai Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Empiai Pharmaceuticals is 27AAACE1822H1Z0, registered in Maharashtra.

The CIN (Corporate Identification Number) of Empiai Pharmaceuticals is U24230MH1988PTC046461. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Empiai Pharmaceuticals has 2 court cases on record: 2 filed by the company.

Empiai Pharmaceuticals was incorporated on 09 March 1988, making it 38+ years old. It is registered with the Registrar of Companies, Mumbai.

Ishan Kishore Adyanthaya ceased to be Additional Director on 30 Sep 2019. Pilar Padmanabha Bhat ceased to be Director on 01 Jan 2019. Ishan Kishore Adyanthaya was appointed as Director on 07 Dec 2018. Empiai Pharmaceuticals has 4 board changes on record in total.

The registered office of Empiai Pharmaceuticals is at 102 Bhagat Singh Road Vile Parle West, Mumbai, Maharashtra, India – 400056.

Empiai Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.